A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis-Reference-Cited by-同舟云学术

A novel Nanoformulation Development of Eugenol and their treatment in inflammation and periodontitis

Published:2019-09 Issue:6 Volume:27 Page:778-790
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Ahmad Niyaz,Ahmad Farhan Jalees,Bedi Sumit,Sharma Sonali,Umar Sadiq,Ansari Mohammad Azam

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference50 articles.

1. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol® gel under Dermaroller® on rats with methyl prednisolone acetate-induced hypertension;Ahad;Biomed. Pharmacother.,2017

2. Quantification and brain targeting of eugenol-loaded surface modified nanoparticles through intranasal route in the treatment of cerebral ischemia;Ahmad;Drug Res. (Stuttg),2018

3. Quantification and evaluation of thymoquinone loaded mucoadhesive nanoemulsion for treatment of cerebral ischemia;Ahmad;Int. J. Biol. Macromol.,2016

4. Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia;Ahmad;Artif. Cells Nanomed. Biotechnol.,2018

5. Ultrasonication techniques used for the preparation of novel Eugenol-Nanoemulsion in the treatment of wounds healings and anti-inflammatory;Ahmad;J. Drug Deliv. Sci. Technol.,2018

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eugenol: The Phytocompound's Potential Biological Applications;BioNanoScience;2024-08-31

2. New Perspectives about Relevant Natural Compounds for Current Dentistry Research;Life;2024-07-29

3. Assessment of acute and subacute toxicity, pharmacokinetics, and biodistribution of eugenol nanoparticles after oral exposure in Wistar rats;Nanotoxicology;2024-01-02

4. Enhancing osteogenic differentiation of MC3T3-E1 cells during inflammation using UPPE/β-TCP/TTC composites via the Wnt/β-catenin pathway;RSC Advances;2024

5. Investigating the Impact of First-Line Anti-Tuberculosis Drugs Encapsulated in a Eugenol-Based Nanoemulsion on Human Serum Albumin;Discovery Medicine;2024